Sanjay Sethi
Press TV, New Delhi
Indian pharmaceutical companies are worried that the new US administration may get tough and curtail imports of medicine from India. It's all to do with the made-in-America campaign that President Donald Trump has promised. This is while India’s export of generic medicine has seen a robust growth in recent years.
From New Delhi, Sanjay Sethi reports.